Trade BTAI anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
BioXcel Therapeutics, Inc. (BTAI) is trading at US$0.17, down 76.35% today as of Aug 28, 13:00 EDT. The company has a market capitalisation of US$25.16M. Over the past 52 weeks, BTAI has traded between US$0.17 and US$4.29. On Syfe you can trade BTAI with $0 commission and add it to your watchlist.
| Previous close | US$0.72 |
|---|---|
| Market cap | US$25.16M |
| 52-week range | US$0.17 – US$4.29 |
| Volume | 1.06M |
| Exchange | US |
Add to Watchlist
Set Price Alert
BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.
Year: 2018
BioXcel Therapeutics Closes $8.0 Million Direct Offering
Mar 11, 9:02 PM · MT Newswires
BioXcel Therapeutics, Inc. (BTAI) stock is trading at US$0.17, -76.35% from the previous close of US$0.72.
The market cap for BioXcel Therapeutics, Inc. (BTAI) stock is approximately US$25.16M.
The 52-week high for BioXcel Therapeutics, Inc. (BTAI) stock is US$4.29.
The 52-week low for BioXcel Therapeutics, Inc. (BTAI) stock is US$0.17.
BioXcel Therapeutics, Inc. (BTAI) does not currently pay a dividend.
Stay on top of BTAI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
